Willkie Farr & Gallagher LLP

05/01/2026 | News release | Distributed by Public on 05/01/2026 11:27

Willkie Advises Caris Life Sciences on New $1.2 Billion Credit Facility

Willkie Advises Caris Life Sciences on New $1.2 Billion Credit Facility

News

share

May 1, 2026

Willkie represented Caris Life Sciences (NASDAQ: CAI), a leader in molecular profiling for diagnosing and treating cancer, in connection with its $1.2 billion credit facility agented by Blue Owl Capital Corporation, providing for senior secured credit facilities consisting of $400 million in initial term loans, $300 million in Delayed Draw Term Loans and $500 million in uncommitted incremental term loans. Proceeds from the initial term loans were used to pay off Caris's existing third-party debt and for general corporate purposes.

The Willkie team was led by partner Gus Atiyah and included counsel Nathan Wood and associates Ashley Shan and Salvatore Mancuso.
Gus Atiyah Partner Finance
New York [email protected] +1 212 728 3062
C. Nathan Wood Counsel Finance
Houston [email protected] +1 713 972 6002
Ashley Shan Associate Finance
New York [email protected] +1 212 728 8119
Salvatore Mancuso Associate Finance
New York [email protected] +1 212 728 3580
Willkie Farr & Gallagher LLP published this content on May 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 01, 2026 at 17:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]